Continuous in vitro culture of Babesia microti
田鼠巴贝斯虫体外连续培养
基本信息
- 批准号:8961269
- 负责人:
- 金额:$ 25.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAgitationAntibodiesAntigensAreaBabesiaBabesia microtiBabesiosisBiologicalBiologyBloodBlood CirculationBlood ScreeningBlood TransfusionBorrelia microtiCD34 geneCarbon DioxideCattleCell AgingCellsCentrifugationCoculture TechniquesCulture MediaDevelopmentDiagnosisDiagnosticDiseaseEnsureEnvironmentEpidemiologyErythrocytesErythroidErythropoiesisFunctional disorderFutureGasesGoalsGrowthHeterogeneityHost-Parasite RelationsHumanIn VitroIndividualInfectionInterventionInvadedInvestigationLongevityMedicineMethodsMovementMusNutrientOptimum PopulationsParasitesParasitologyPhasePhysical environmentPlasmodiumPlasmodium falciparumPopulationPreventionProtocols documentationReagentReportingResearchResourcesReticulocytesSafetySerumSolutionsSourceStagingSupplementationSuspension substanceSuspensionsSystemTestingTicksTransfusionUmbilical Cord BloodUmbilical cord structureUnited StatesZoonosesage relatedblood productcell agedensityerythroid differentiationexperienceinnovationinsightinterestmonolayerneglectnovelparasite invasionpathogenperipheral bloodpublic health relevancesafety studytissue culturetransmission process
项目摘要
DESCRIPTION (provided by applicant): The ability to cultivate parasites in vitro has resulted in rapid progress in the understanding of host-parasite relationships, parasite biology and pathophysiology. Conversely, the lack of a parasite in vitro culture system can severely hamper studies on that specific pathogen as seen in Babesia microti-caused babesiosis. This is true despite the mounting evidence for the emergence and spread of B. microti in the US and its dominating status as a threat to transfusion medicine. The overall goal of our proposal is to establish a continuous in vitro culture system of B. microti in human RBCs to enable a platform amenable for future experimental investigation. It is well known that human RBCs which serve as the cellular vehicle host for Babesia are not a uniform, homogenous population of cells in circulation and undergo many age related transformations in their 120 day life span. Our hypothesis is that these heterogeneous RBCs are not equal hosts for B. microti invasion and growth. The two specific aims in our proposal will test this hypothesis and assess if parasite invasion and proliferation in human RBCs would occur when presented with a uniform RBC population of the optimum age and features. Specific Aim 1 addresses the identification of specific human RBC sub-populations that would support optimum invasion and replication of B. microti in vitro and Specific Aim 2 will define culture conditions (gas, media, shaking vs static) needed to support this invasion and replication of B. microti in vitro. By combining our extensive experience in parasitology (Lobo and Narla, P. falciparum and B. divergens) together with the red cell expertise (Narla) and reagents (Human sources of B. microti, umbilical cord cell resources, antibodies, and antigens) available at NYBC, we will obtain insights into the specific RBC lineage favored by B. microti. This study is the first systematic analysis of culture conditions required for parasite propagation and is a necessary first step in the search for reagents for diagnosis, epidemiology, treatment and prevention of human babesiosis, as well as to assist in developing novel methods to screen blood products.
描述(由适用提供):体外培养寄生虫的能力在理解宿主 - 寄生虫关系,寄生虫生物学和病理生理学方面取得了迅速的进展。相反,缺乏体外培养系统的寄生虫可能会严重阻碍有关该特定病原体的研究。这是真正的目的地,证明了Microti在美国的出现和传播及其主导地位作为对翻译医学的威胁。我们提案的总体目标是建立人类RBC中Microti的连续体外培养系统,以实现适合未来实验研究的平台。众所周知,作为贝贝西亚的细胞载体宿主的人类RBC并不是循环中的统一细胞群体,并且在其120天寿命中经历了许多与年龄相关的转变。我们的假设是,这些异质的RBC并不是小芽孢杆菌入侵和生长的宿主。我们的提案中的两个具体目标将检验该假设和评估,当在最佳年龄和特征的RBC人群中出现时,人类RBC的寄生虫入侵和增殖是否会发生。具体目的1解决了特定人类RBC亚群的鉴定,这些识别将支持在体外的最佳侵袭和复制,并且特定目标2将定义培养条件(气体,媒体,摇动与静态),以支持这种侵袭和复制Microti在体外。通过将我们在寄生虫学(Lobo和Narla,P。falciparum和B. divergens)和红细胞专业知识(NARLA)和试剂(Microti B. microti,脐带细胞资源,脐细胞资源,抗体和抗原的人体来源(人体来源)相结合,我们将在Nybc中获得互联网,B。这项研究是对寄生虫传播所需的培养条件进行的首次系统分析,是寻找诊断,流行病学,治疗和预防人类Babesiosis的试剂的必要第一步,并有助于开发筛查血液产品的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cheryl Ann Lobo其他文献
Cheryl Ann Lobo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cheryl Ann Lobo', 18)}}的其他基金
Babesia: Extracellular Vesicles and their Role in Intercellular Communication
巴贝斯虫:细胞外囊泡及其在细胞间通讯中的作用
- 批准号:
9307089 - 财政年份:2017
- 资助金额:
$ 25.71万 - 项目类别:
Babesiosis: An Emerging Infectious Threat to Transfusion Medicine
巴贝斯虫病:对输血医学的新的感染威胁
- 批准号:
8434112 - 财政年份:2011
- 资助金额:
$ 25.71万 - 项目类别:
Babesiosis: An Emerging Infectious Threat to Transfusion Medicine
巴贝斯虫病:对输血医学的新的感染威胁
- 批准号:
8243503 - 财政年份:2011
- 资助金额:
$ 25.71万 - 项目类别:
Babesiosis: An Emerging Infectious Threat to Transfusion Medicine
巴贝斯虫病:对输血医学的新的感染威胁
- 批准号:
8022336 - 财政年份:2011
- 资助金额:
$ 25.71万 - 项目类别:
Babesiosis: An Emerging Infectious Threat to Transfusion Medicine
巴贝斯虫病:对输血医学的新的感染威胁
- 批准号:
8829318 - 财政年份:2011
- 资助金额:
$ 25.71万 - 项目类别:
Babesiosis: An Emerging Infectious Threat to Transfusion Medicine
巴贝斯虫病:对输血医学的新的感染威胁
- 批准号:
8645704 - 财政年份:2011
- 资助金额:
$ 25.71万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Epidemiology and Clinical Outcomes of Electroconvulsive Therapy Use in Nursing Home Residents with Dementia
痴呆症疗养院居民的流行病学和电休克治疗的临床结果
- 批准号:
10661910 - 财政年份:2023
- 资助金额:
$ 25.71万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health TABA Supplement
使用 Jaspr Health TABA 补充剂治疗初级保健中的自杀驱动者
- 批准号:
10805635 - 财政年份:2023
- 资助金额:
$ 25.71万 - 项目类别:
Addressing Hearing Loss as a Common Unmet Contributor to Neuropsychiatric Symptoms
解决听力损失作为神经精神症状的常见未得到解决的原因
- 批准号:
10641903 - 财政年份:2022
- 资助金额:
$ 25.71万 - 项目类别:
Addressing Hearing Loss as a Common Unmet Contributor to Neuropsychiatric Symptoms
解决听力损失作为神经精神症状的常见未得到解决的原因
- 批准号:
10417874 - 财政年份:2022
- 资助金额:
$ 25.71万 - 项目类别:
Unraveling the neural basis of female aggression and dementia-related aggression: a systems biology approach.
揭示女性攻击性和痴呆相关攻击性的神经基础:系统生物学方法。
- 批准号:
10633263 - 财政年份:2022
- 资助金额:
$ 25.71万 - 项目类别: